Author

Cory J. Berkland

University of KansasORCID 0000-0002-9346-938XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2

Frequent Co-Authors

Amber Simone GriffithiD· 1 shared Amy W. KuiD· 1 shared Camillo Bechi GenzanoiD· 1 shared Fernando A. Ocampo Gonzalez· 1 shared Grant M. DownesiD· 1 shared Joshua D. MilneriD· 1 shared Joshua O. Sestak· 1 shared Kyle D. ApleyiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amber Simone GriffithORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyFrontiers in ImmunologyPeer-reviewedJun 12, 2024

Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy

Rebuma Firdessa-Fite, Stephanie N. Johnson, Camillo Bechi Genzano…·Rémi J. Creusot

This study shows that soluble antigen arrays (SAgAs) enhance the efficacy and safety of peptide-based immunotherapy compared to free peptides in treating autoimmune diabetes.

5 citations

mouseproteomics

𝕏 PostBluesky

BioengineeringBioconjugate ChemistryPeer-reviewedOct 26, 2023

CD22L Conjugation to Insulin Attenuates Insulin-Specific B cell Activation

Kyle D. Apley, Amber Simone Griffith, Grant M. Downes…·Cory J. Berkland

This paper develops insulin-CD22L conjugates to inhibit anti-insulin B cells in T1D, finding that low-valency conjugates reduce B cell activation while high-valency ones promote it.

5 citations

mouseproteomics

𝕏 PostBluesky